On July 17, 2024, the Food and Drug Administration (FDA) carried out a bioresearch monitoring inspection at the office of Dustin R. Fraidenburg, M.D. located in Chicago, according to data posted on the FDA's website.

According to the final report, Dustin R. Fraidenburg, M.D. was not required to implement any corrective actions related to the management of the organization’s operations.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal d

See Full Page